Literature DB >> 15459433

Identifying thresholds for penumbra and irreversible tissue damage.

Wolf-Dieter Heiss1, Jan Sobesky, Volker Hesselmann.   

Abstract

Diffusion-weighted MRI (DWI) in combination with perfusion-weighted MRI (PWI) has become a widely accepted modality for the selection of patients amenable for acute therapy, if a mismatch between these procedures suggests viable penumbral tissue. However, DWI as well as PWI yields semiquantitative measures limiting the definitions of irreversible damage and of potentially viable penumbral tissue. These limitations of PWI/DWI may be better understood if findings in individual patients are compared with the results from measurements of blood flow, oxygen metabolism, and benzodiazepine receptor binding obtained with positron emission tomography (PET). Comparative studies with PET and MRI were performed in 3 groups of patients: (1) In 12 acute stroke patients, results from DWI (median, 6.5 hours after symptom onset) and 11C-flumazenil (FMZ) PET (median, 85 minutes between DWI and PET) were compared with infarct extension 24 to 48 hours later on T2-weighted MRI. (2) In 11 acute stroke patients, results from PWI (median, 8 hours after symptom onset) were compared with cerebral blood flow measurements obtained with [15O]H2O PET (interval, 60 minutes between PWI and PET). (3) In 10 patients with acute (n=5) or chronic stroke (n=5), results from PWI/DWI were compared with PET of cerebral blood flow and oxygen consumption to detect mismatch or increased oxygen extraction fraction as surrogate markers of penumbra. Results were: (1) from regions with increased DWI intensity, decreased apparent diffusion coefficient (ADC) and decreased FMZ binding probability curves were computed for eventual infarction, and 95% prediction limits were determined. These limits predicted 83.5% (FMZ), 84.7% (DWI), and 70.9% (ADC) of the final infarct volume. However, the false-positive predictions were much higher for the DWI variables (5.1 and 3.6 cm3 for DWI and ADC versus a median of 0 for FMZ). (2) The comparison of volumes generated by different time to peak (TTP) thresholds (PWI) and hypoperfusion <20 mL/100 g per minute (PET) indicates that a TTP delay of 4 to 6 seconds yields a fair estimate of hypoperfusion. (3) The PWI/DWI mismatch with TTP >4 seconds did not reliably correspond to the penumbra as assessed by PET (oxygen extraction fraction >150%). Only 6 of 10 patients with a mismatch had areas of penumbra. In these cases, the penumbra volume was overestimated by MRI. DWI correlates with FMZ results and, with a few exceptions, yields a good estimate of acute tissue damage and final infarct volume. PWI measures seem to be less reliable; the TTP prolongation of >4 seconds assessed only 83% of the volume of hypoperfusion <20 mL/100 g per minute. The mismatch volume imprecisely depicts increased oxygen extraction fraction, and, despite its clinical role for selection of patients for eventual therapy, it does not to seem to be a reliable correlate of penumbra.

Entities:  

Mesh:

Year:  2004        PMID: 15459433     DOI: 10.1161/01.STR.0000143329.81997.8a

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

Review 1.  Neuroimaging of cerebral ischemia and infarction.

Authors:  Carlos Leiva-Salinas; Max Wintermark; Chelsea S Kidwell
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  The two pathophysiologies of focal brain ischemia: implications for translational stroke research.

Authors:  Konstantin-Alexander Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-11       Impact factor: 6.200

3.  Venous oxygenation mapping using velocity-selective excitation and arterial nulling.

Authors:  Jia Guo; Eric C Wong
Journal:  Magn Reson Med       Date:  2012-01-31       Impact factor: 4.668

4.  Imaging of acute ischemic stroke.

Authors:  Carlos Leiva-Salinas; Max Wintermark
Journal:  Neuroimaging Clin N Am       Date:  2010-11       Impact factor: 2.264

5.  PET Detection of Cerebral Necrosis Using an Infarct-Avid Agent 2-Deoxy-2-[18F]Fluoro-D-Glucaric Acid (FGA) in a Mouse Model of the Brain Stroke.

Authors:  Hailey Houson; Alexander Mdzinarishvili; Hariprasad Gali; Evgeny Sidorov; Vibhudutta Awasthi
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

6.  Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis.

Authors:  Daniel Sanák; Vladimír Nosál'; David Horák; Andrea Bártková; Kamil Zelenák; Roman Herzig; Jirí Bucil; David Skoloudík; Stanislav Burval; Viera Cisariková; Ivanka Vlachová; Martin Köcher; Jana Zapletalová; Egon Kurca; Petr Kanovský
Journal:  Neuroradiology       Date:  2006-08-29       Impact factor: 2.804

7.  [Development of neuroradiology. From the visualization of bones to molecular imaging].

Authors:  W Reith
Journal:  Radiologe       Date:  2005-04       Impact factor: 0.635

Review 8.  The potential of PET/MR for brain imaging.

Authors:  Wolf-Dieter Heiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

9.  Oxygen metabolism in ischemic stroke using magnetic resonance imaging.

Authors:  Hongyu An; Qingwei Liu; Yasheng Chen; Katie D Vo; Andria L Ford; Jin-Moo Lee; Weili Lin
Journal:  Transl Stroke Res       Date:  2011-12-13       Impact factor: 6.829

10.  Improving acute stroke management with computed tomography perfusion: a review of imaging basics and applications.

Authors:  C D d'Esterre; Enrico Fainardi; R I Aviv; T Y Lee
Journal:  Transl Stroke Res       Date:  2012-05-24       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.